YW

Yaolin Wang

IC Inventisbio Co.: 10 patents #3 of 10Top 30%
SC Schering: 5 patents #587 of 2,442Top 25%
WC Wuhan Tianma Microelectronics Co.: 5 patents #70 of 395Top 20%
Merck: 4 patents #2,506 of 9,382Top 30%
LL Lyvgen Biopharma Holdings Limited: 1 patents #3 of 4Top 75%
Overall (All Time): #156,810 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12427146 C-terminal SRC kinase inhibitors Xing Dai, Yueheng Jiang, Yanqin LIU, Zhe SHI, Zhenwu Wang +2 more 2025-09-30
12391677 Thyroid hormone receptor agonists Xing Dai, Yueheng Jiang, Yanqin LIU, Zixing HAN, Zhenwu Wang +2 more 2025-08-19
12187736 Selective estrogen receptor degraders and uses thereof Xing Dai 2025-01-07
12173010 Heterocyclic compounds, preparation methods therefor, and methods of uses thereof Xing Dai, Yueheng Jiang, Yanqin LIU, Haotao NIU, Zhenwu Wang +4 more 2024-12-24
12110289 Heterocyclic compounds, preparation methods and uses thereof Xing Dai, Yueheng Jiang, Yanqin LIU, Zhe SHI, Zhenwu Wang +4 more 2024-10-08
12094384 Display panel and display device with reduced charge accumulation in semiconductor layer Zhiyong Xiong, Rui Ding 2024-09-17
11969425 Inhibitor of indoleamine-2,3-dioxygenase (IDO) Xing Dai 2024-04-30
11900876 Display panel, method for driving the same, and display apparatus 2024-02-13
11847960 Display panel, method for driving the same, and display apparatus Zhiyong Xiong 2023-12-19
11699373 Display panel and display device with reduced charge accumulation in semiconductor layer Zhiyong Xiong, Rui Ding 2023-07-11
11691981 Heterocyclic compounds, preparation methods therefor, and methods of uses thereof Xing Dai, Yueheng Jiang, Yanqin LIU, Haotao NIU, Zhenwu Wang +4 more 2023-07-04
11374084 Organic light emitting display panel and display device 2022-06-28
11014936 Selective estrogen receptor degraders and uses thereof Xing Dai 2021-05-25
10980807 Inhibitor of indoleamine-2,3-dioxygenase (IDO) Xing Dai 2021-04-20
10913797 Anti-PD-1 antibodies and therapeutic uses thereof Jieyi Wang, Liqun Dong 2021-02-09
10647724 Selective estrogen receptor degraders and uses thereof Xing Dai 2020-05-12
9540377 2,6,7,8 substituted purines as HDM2 inhibitors Carolyn Michele Cammarano, Matthew Christopher, Christopher J. Dinsmore, Ronald J. Doll, Francesc Xavier Fradera Llinas +16 more 2017-01-10
9062071 Substituted piperidines as HDM2 inhibitors Yao-Dong Ma, Manami Shizuka, Timothy J. Guzi, Yuan Liu, Yuan Tian +10 more 2015-06-23
8859776 Substituted piperidines that increase p53 activity and the uses thereof Stephane L. Bogen, Yao-Dong Ma, Brian Robert Lahue, Latha G. Nair, Manami Shizuka +15 more 2014-10-14
8034907 Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides Shahriar Shane Taremi, Gaolian Xie, Thomas Hesson, Jose S. Duca, Corey Strickland +4 more 2011-10-11
7888474 HDM2 polypeptides Thomas Hesson, Hung V. Le, Yao-Dong Ma, Vincent S. Madison, Anthony F. Mannarino +6 more 2011-02-15
7884107 Substituted piperidines that increase P53 activity and the uses thereof Yao-Dong Ma, Brian Robert Lahue, Gerald W. Shipps, Jr., Stephane L. Bogen, Matthew E. Voss +10 more 2011-02-08
7811562 Biomarkers for pre-selection of patients for anti-IGF1R therapy Yan Wang, Jonathan A. Pachter, Ming-Cheng Liu 2010-10-12
7705127 HDM2 Polypeptides Thomas Hesson, Hung V. Le, Yao-Dong Ma, Vincent S. Madison, Anthony F. Mannarino +6 more 2010-04-27
7632920 Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof Shahriar Shane Taremi, Gaolian Xie, Thomas Hesson, Jose S. Duca, Corey Strickland +4 more 2009-12-15